Kymera Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $403k | 10k | 40.24 |
| 2023-12-31 | $229k | 9.0k | 25.40 |
| 2023-06-30 | $207k | 9.0k | 22.96 |
| 2023-03-31 | $267k | 9.0k | 29.62 |
| 2022-12-31 | $225k | 9.0k | 24.96 |
| 2022-03-31 | $381k | 9.0k | 42.27 |
| 2021-12-31 | $572k | 9.0k | 63.46 |
| 2021-09-30 | $529k | 9.0k | 58.69 |
| 2021-06-30 | $442k | 9.1k | 48.50 |
| 2021-03-31 | $350k | 9.0k | 38.83 |
| 2020-12-31 | $559k | 9.0k | 62.01 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors